問卷

TPIDB > Search Result

Search Result

篩選

List

1364Cases

2014-01-01 - 2020-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2013-12-01 - 2022-12-31

Phase III

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B
  • Condition/Disease

    Chronic Hepatitis B

  • Test Drug

    1.Tenofovir Alafenamide (TAF, GS-7340)、 2.Tenofovir Disoproxil Fumarate (TDF, Viread®)

Participate Sites
8Sites

Terminated8Sites

2013-02-01 - 2021-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2011-03-01 - 2018-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2015-11-24 - 2019-12-31

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2017-02-01 - 2018-01-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Study ended1Sites

2016-08-01 - 2018-07-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Study ended1Sites

2014-08-01 - 2016-07-31

Phase IV

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2019-08-01 - 2022-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2019-01-01 - 2020-02-05

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites